as on March 11, 2026 at 6:59 am IST
Day's Low
Day's High
5.18%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
54.37%
Downside
10.51%
Upside
Check Cytokinetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.4B
EPS (TTM)
-6.4391
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-12.38
Industry PE ratio
7.871681415929204
PEG Ratio
-0.42
EBITDA
-602.1M
Revenue (TTM)
88.0M
Profit Margin
0.00%
Return On Equity TTM
-572.15%
Track how Cytokinetics Inc P/E has moved over time to understand its valuation trends.
Cytokinetics Inc in the last 5 years
Lowest (-15.74x)
June 30, 2022
Today (-12.38x)
March 10, 2026
Industry (7.87x)
March 10, 2026
Highest (-6.03x)
September 30, 2023
Today’s Price to Earnings Ratio: -12.38x
Compare market cap, revenue, PE, and other key metrics of Cytokinetics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $7.4B | 216.85% | -12.38 | 0.00% | |
| BUY | $42.5B | 140.27% | 137.03 | 8.45% | |
| BUY | $116.0B | 115.07% | 29.85 | 32.94% | |
| NA | $33.3B | NA | 590.43 | 5.37% | |
| BUY | $80.3B | 67.03% | 18.31 | 31.41% |
The Cytokinetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cytokinetics Inc investment value today
Current value as on today
₹1,53,495
Returns
₹53,495
(+53.5%)
Returns from Cytokinetics Inc Stock
₹48,303 (+48.3%)
Dollar Returns*
₹5,192 (+5.19%)
Based on 25 analysts
84.00%
Buy
16.00%
Hold
0.00%
Sell
Based on 25 analysts, 84% of analysts recommend a 'BUY' rating for Cytokinetics Inc. Average target price of $91.17
Get share price movements and forecasts by analysts on Cytokinetics Inc.
What analysts predicted
29.55%UPSIDE
Target Price
$91.17
Current Price
$64.23
Analyzed by
25 Analysts
Target
$91.17
Cytokinetics Inc target price $91.17, a slight upside of 29.55% compared to current price of $64.23. According to 25 analysts rating.
Search interest for Cytokinetics Inc Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 18 September
Thu, 06:00 PM
-Cytokinetics faces class action lawsuit for misleading investors about FDA drug approval timeline and omitted key regulatory requirements.
Fri, 02:35 AM
-Cytokinetics stock dropped over 15% after FDA extended review period for aficamten due to incomplete submission.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -306.17M → -183.03M (in $), with an average increase of 67.3% per quarter
Price Rise
![]()
In the last 7 days, CYTK stock has moved up by 2.8%
Best in 1 Year
![]()
In the last 1 year, CYTK has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 1.93M → 17.75M (in $), with an average increase of 89.1% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 1.9%
| Organisation | Cytokinetics Inc |
| Headquarters | 350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Mr. Robert I. Blum |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Robert I. Blum | CEO, President & Director |
Mr. Sung H. Lee | EVP & CFO |
Dr. Fady Ibraham Malik FACC, M.D., Ph.D. | Executive Vice President of Research & Development |
Mr. Andrew M. Callos | Executive VP & Chief Commercial Officer |
Dr. James H. Sabry M.D., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Mr. Jeff Lotz | Vice President of Sales & Operations |
Mr. Jeffrey J. Hessekiel J.D. | Executive VP, Chief Legal & Administrative Officer |
Dr. James A. Spudich Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Ms. Holly Laughlin | VP of Accounting & Corporate Controller |
Mr. Steven M. Cook J.D. | Senior Vice President of Global Supply Chain Operations & Technical Operations |
Cytokinetics Inc share price today is $64.23 as on . Cytokinetics Inc share today touched a day high of $64.66 and a low of $60.9.
Cytokinetics Inc share touched a 52 week high of $70.98 on and a 52 week low of $29.31 on . Cytokinetics Inc stock price today i.e. is trending at $64.23,which is 9.51% down from its 52 week high and 119.14% up from its 52 week low.
Cytokinetics Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Cytokinetics Inc (CYTK) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Cytokinetics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cytokinetics Inc share’s latest price of $64.23 as on March 11, 2026 at 1:29 am IST, you will get 0.1557 shares of Cytokinetics Inc. Learn more about
fractional shares .
Cytokinetics Inc stock has given 216.85% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?